Shopping Cart
- Remove All
- Your shopping cart is currently empty
MDG506 is a novel selective androgen receptor (AR) interaction disruptor that demonstrates low cytotoxicity in prostate cancer (PCa) models and shows a dose-dependent reduction in prostate-specific antigen expression induced by classical antiandrogens.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | MDG506 is a novel selective androgen receptor (AR) interaction disruptor that demonstrates low cytotoxicity in prostate cancer (PCa) models and shows a dose-dependent reduction in prostate-specific antigen expression induced by classical antiandrogens. |
Alias | MDG 506, MDG-506 |
Molecular Weight | 425.52 |
Formula | C23H24FN3O2S |
Cas No. | 933005-54-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.